Vibha Ravi
Senior Editor, Citeline - Scrip, Pink Sheet. Tweets on pharma, health, environment, other topics of interest to those who read beyond headlines, social media
Articles
-
2 weeks ago |
insights.citeline.com | Joseph Haas |Lisa Takagi |Vibha Ravi |Sushmita Panda
Asia Deal Watch: Otsuka’s Taiho Licenses LSD1 Inhibitor Rights To BenzPlus deals involving BioAge/JiKang, Sanyou/Medicovestor, AriBio/Acino, Intragrand/Transpire, Kaken/Twocells, Sumitomo/Novo Nordisk, NIBEC/Undisclosed, Formosa/Adalvo, Drug Farm/Amoytop, Lupin/SteinCares and Lupin/Honeywell.
-
2 weeks ago |
insights.citeline.com | Vibha Ravi
Is Zydus’s Agenus Deal Opportunistic Or Strategic? Will Zydus’s acquisition and licensing deal with Agenus turn out to be a strategic move towards building an oncology portfolio or an opportunistic one driven by a venture capital mindset? Zydus Has Made Several Acquisitions In Quick Succession (Shutterstock)
-
3 weeks ago |
insights.citeline.com | Vibha Ravi
Loss Of Exclusivity Product Launches To Fuel Aurobindo’s FY26 Europe GrowthFY28 Inflection Point For BiosimilarsAurobindo is banking on launches of loss of exclusivity products and biosimilars to fuel sales in Europe as it awaits a US announcement on tariffs and predicts high single-digit growth overall during FY26 for nowAurobindo Sees Safety On Europe's Shores Amid Fog In The US (Shutterstock)
-
3 weeks ago |
insights.citeline.com | Vibha Ravi
ASCO: Lupin Presents Early Data On PRMT5 InhibitorASCO sees the debut of Lupin’s PRMT5 inhibitor candidate LRNP7457, currently in Phase I studies in India. While no drug in the class has been approved anywhere for cancer so far, several candidates are in clinical trials. ASCO 2025 Meeting (Alaric DeArment)
-
1 month ago |
insights.citeline.com | Vibha Ravi
Loss Of Exclusivity Product Launches To Fuel Aurobindo’s FY26 Europe GrowthFY28 Inflection Point For BiosimilarsAurobindo is banking on launches of loss of exclusivity products and biosimilars to fuel sales in Europe as it awaits a US announcement on tariffs and predicts high single-digit growth overall during FY26 for nowAurobindo Seeks Safety On Europe's Shores Amid Fog In The US (Shutterstock)
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 673
- Tweets
- 4K
- DMs Open
- Yes
RT @Citeline: BREAKING! https://t.co/Dr9A5uv5qu #CitelineBreakingNews #Scrip #NovoNordisk _____ Follow @Citeline News & Insights for in-de…
How to apply for the Global Generics & Biosimilars Award from Generics Bulletin, Citeline - @DaveGenerics shares all the details to nominate, sponsor and attend #awards #Citeline #pharmaceutical @Citeline https://t.co/tZp8019MNl
How will Indian CRDMOs be affected by big pharma's US manufacturing investments, possible US tariffs, lower funding? Listen to Aragen Life CEO and IPSO co-chair Manni Kantipudi #podcast #Tariffs #business @AragenBio https://t.co/C5w93H7SWQ